Computerised cognitive testing could help predict disease progression in relapsing-remitting multiple sclerosis (RRMS) patients and better inform treatment decisions, according to Australian neurologists. A study of 460 RRMS patients enrolled in Monash University’s online cognitive performance tracker ‘MSRreactor’ between 2016 and 2019 showed that visual attention and working memory tasks could identify patients who were ...
Cognitive testing may predict RRMS progression
By Natasha Doyle
12 Oct 2021